Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Podocytes | 13 | 2023 | 85 | 2.350 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 11 | 2023 | 41 | 1.980 |
Why?
|
Kidney Diseases | 5 | 2023 | 115 | 1.000 |
Why?
|
Glomerulosclerosis, Focal Segmental | 6 | 2023 | 44 | 0.830 |
Why?
|
Proteinuria | 10 | 2023 | 81 | 0.790 |
Why?
|
Mice | 13 | 2023 | 1620 | 0.610 |
Why?
|
Kidney | 3 | 2018 | 173 | 0.550 |
Why?
|
Animals | 16 | 2023 | 4577 | 0.520 |
Why?
|
Mice, Transgenic | 7 | 2023 | 250 | 0.410 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 49 | 0.390 |
Why?
|
Glomerular Filtration Rate | 3 | 2019 | 59 | 0.340 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 50 | 0.310 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 284 | 0.270 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2016 | 97 | 0.250 |
Why?
|
Immunotoxins | 1 | 2023 | 2 | 0.240 |
Why?
|
Integrins | 1 | 2023 | 19 | 0.230 |
Why?
|
Disease Models, Animal | 4 | 2020 | 726 | 0.230 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 29 | 0.230 |
Why?
|
Kidney Glomerulus | 3 | 2016 | 54 | 0.230 |
Why?
|
Signal Transduction | 3 | 2019 | 483 | 0.230 |
Why?
|
Hyperglycemia | 1 | 2023 | 34 | 0.230 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2023 | 6 | 0.230 |
Why?
|
Sepsis | 1 | 2023 | 144 | 0.200 |
Why?
|
HEK293 Cells | 2 | 2019 | 70 | 0.200 |
Why?
|
Biopsy | 2 | 2019 | 234 | 0.190 |
Why?
|
Humans | 14 | 2023 | 29361 | 0.190 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2020 | 5 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 1 | 2020 | 42 | 0.180 |
Why?
|
Coronary Angiography | 1 | 2020 | 91 | 0.180 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2019 | 2 | 0.180 |
Why?
|
Receptor, PAR-2 | 1 | 2019 | 3 | 0.170 |
Why?
|
Protein Domains | 1 | 2019 | 10 | 0.170 |
Why?
|
Adipocytes | 1 | 2019 | 11 | 0.170 |
Why?
|
Protein Multimerization | 1 | 2019 | 18 | 0.170 |
Why?
|
Microscopy, Electron | 1 | 2019 | 70 | 0.170 |
Why?
|
Protein Isoforms | 1 | 2019 | 53 | 0.170 |
Why?
|
Annulus Fibrosus | 1 | 2018 | 9 | 0.170 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2018 | 34 | 0.170 |
Why?
|
Endoplasmic Reticulum-Associated Degradation | 1 | 2017 | 2 | 0.160 |
Why?
|
Wnt Signaling Pathway | 1 | 2018 | 33 | 0.160 |
Why?
|
Adipose Tissue | 1 | 2018 | 74 | 0.160 |
Why?
|
Endoplasmic Reticulum | 1 | 2017 | 28 | 0.160 |
Why?
|
Diabetic Nephropathies | 1 | 2017 | 27 | 0.150 |
Why?
|
Bone and Bones | 1 | 2018 | 125 | 0.150 |
Why?
|
Intervertebral Disc Degeneration | 1 | 2018 | 116 | 0.150 |
Why?
|
TRPC Cation Channels | 3 | 2023 | 11 | 0.150 |
Why?
|
Myeloid Cells | 1 | 2016 | 16 | 0.150 |
Why?
|
Intervertebral Disc | 1 | 2018 | 212 | 0.140 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 220 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2017 | 173 | 0.140 |
Why?
|
Integrin beta3 | 1 | 2015 | 6 | 0.140 |
Why?
|
Plasma Exchange | 1 | 2015 | 15 | 0.140 |
Why?
|
Cells, Cultured | 6 | 2018 | 676 | 0.130 |
Why?
|
Hydroxyquinolines | 1 | 2015 | 4 | 0.130 |
Why?
|
Integrin beta1 | 1 | 2015 | 9 | 0.130 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 92 | 0.130 |
Why?
|
Biomarkers | 4 | 2023 | 692 | 0.130 |
Why?
|
Sulfonamides | 1 | 2015 | 54 | 0.130 |
Why?
|
Retrospective Studies | 3 | 2019 | 3273 | 0.120 |
Why?
|
Mice, Knockout | 4 | 2017 | 304 | 0.120 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 432 | 0.120 |
Why?
|
Lipopolysaccharides | 2 | 2015 | 127 | 0.110 |
Why?
|
Cell Movement | 2 | 2015 | 105 | 0.110 |
Why?
|
Kidney Transplantation | 1 | 2013 | 125 | 0.100 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 21 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 76 | 0.100 |
Why?
|
TRPC6 Cation Channel | 3 | 2023 | 8 | 0.090 |
Why?
|
Aging | 1 | 2018 | 1594 | 0.080 |
Why?
|
Membrane Microdomains | 1 | 2007 | 15 | 0.080 |
Why?
|
Integrin alphaVbeta3 | 1 | 2007 | 21 | 0.080 |
Why?
|
Gene Transfer Techniques | 1 | 2007 | 35 | 0.080 |
Why?
|
Cathepsins | 1 | 2007 | 7 | 0.080 |
Why?
|
Dynamins | 1 | 2007 | 10 | 0.080 |
Why?
|
Cysteine Endopeptidases | 1 | 2007 | 9 | 0.080 |
Why?
|
Cytoskeleton | 3 | 2014 | 51 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 340 | 0.070 |
Why?
|
Models, Biological | 1 | 2007 | 344 | 0.070 |
Why?
|
Middle Aged | 5 | 2020 | 9823 | 0.060 |
Why?
|
Male | 6 | 2020 | 15637 | 0.060 |
Why?
|
Calcium Channels | 1 | 2005 | 130 | 0.060 |
Why?
|
Recurrence | 2 | 2015 | 350 | 0.060 |
Why?
|
Female | 5 | 2020 | 16211 | 0.060 |
Why?
|
Insulin | 1 | 2023 | 92 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 157 | 0.050 |
Why?
|
Actins | 2 | 2015 | 45 | 0.050 |
Why?
|
Adult | 4 | 2019 | 8604 | 0.050 |
Why?
|
Time Factors | 2 | 2017 | 1618 | 0.050 |
Why?
|
Inflammation | 1 | 2023 | 345 | 0.050 |
Why?
|
Kidney Tubules | 1 | 2020 | 10 | 0.050 |
Why?
|
Cathepsin L | 2 | 2011 | 9 | 0.050 |
Why?
|
Rats | 2 | 2015 | 858 | 0.040 |
Why?
|
Odds Ratio | 1 | 2020 | 285 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 10 | 0.040 |
Why?
|
Nucleus Pulposus | 1 | 2018 | 12 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 260 | 0.040 |
Why?
|
Growth Plate | 1 | 2018 | 23 | 0.040 |
Why?
|
Critical Illness | 1 | 2020 | 123 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2011 | 323 | 0.040 |
Why?
|
Bone Development | 1 | 2018 | 35 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2018 | 146 | 0.040 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2017 | 7 | 0.040 |
Why?
|
Proteolysis | 1 | 2017 | 13 | 0.040 |
Why?
|
Protein Folding | 1 | 2017 | 18 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 264 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2020 | 301 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 161 | 0.040 |
Why?
|
Chondrocytes | 1 | 2018 | 197 | 0.040 |
Why?
|
Mice, SCID | 1 | 2016 | 55 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 678 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2016 | 57 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2016 | 44 | 0.040 |
Why?
|
Apoptosis | 1 | 2017 | 251 | 0.040 |
Why?
|
Puromycin Aminonucleoside | 1 | 2015 | 7 | 0.030 |
Why?
|
Focal Adhesions | 1 | 2015 | 9 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 10 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 162 | 0.030 |
Why?
|
Albuminuria | 1 | 2015 | 21 | 0.030 |
Why?
|
Linear Models | 1 | 2015 | 254 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 116 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2015 | 88 | 0.030 |
Why?
|
Mutation | 2 | 2007 | 383 | 0.030 |
Why?
|
Biological Transport, Active | 1 | 2014 | 16 | 0.030 |
Why?
|
Aged | 2 | 2020 | 9447 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 148 | 0.030 |
Why?
|
Phenotype | 1 | 2015 | 357 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2013 | 14 | 0.030 |
Why?
|
Rituximab | 1 | 2013 | 53 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 38 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2020 | 957 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2013 | 125 | 0.030 |
Why?
|
Incidence | 1 | 2015 | 756 | 0.030 |
Why?
|
Disease Progression | 1 | 2015 | 788 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 132 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2011 | 13 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2011 | 31 | 0.030 |
Why?
|
Cell Survival | 1 | 2011 | 169 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2015 | 1829 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 173 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 1812 | 0.020 |
Why?
|
Young Adult | 1 | 2013 | 1935 | 0.020 |
Why?
|
Transfection | 1 | 2006 | 125 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2006 | 251 | 0.020 |
Why?
|
Gene Expression | 1 | 2006 | 226 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2005 | 3 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 1 | 2005 | 4 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 453 | 0.020 |
Why?
|
Pedigree | 1 | 2005 | 77 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 3476 | 0.020 |
Why?
|
Adolescent | 1 | 2005 | 2280 | 0.010 |
Why?
|